In the foreground, pharmaceutical and biotechnology companies bring new drugs and products to market. In the background, they rely on content management technologies to securely store, maintain, and distribute documents critical to their processes. Documentum-based content management systems support pre-market testing and FDA submissions-activities that require thousands of pages of documentation. Further, these systems help companies stay on track in the years leading up to approval.
Trinity’s products are based on Documentum enterprise content management software. EMC/Documentum is the optimal solution for companies competing in the demanding biotech and pharmaceutical services sector. As it streamlines, automates, and integrates business processes, EMC/Documentum complements Trinity’s core expertise of synchronizing workflows with proven technology.
ISE (pronounced “eyes”) allows Documentum users to perform full text searches on virtually any file format, including drawings
Easily export content for information sharing or archiving.
Integrate Documentum with a range of information systems focued on financial, maintenance management, GIS and engineering content.
Aventis Pharmaceuticals, ISIS Pharmaceuticals, Merck
Real Life Use
About twenty workers in a pharmaceutical company use DocExport to export documents to CD for submissions to health authorities. When dossiers are required, DocExport can quickly export the documents from Documentum while meeting the agency's specifications for electronic submissions.